- Home
- TARA vs CMT Comparison
TARA vs CMT Comparison
Compare TARA & CMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- CMT
- Stock Information
- Founded
- TARA N/A
- CMT 1996
- Country
- TARA United States
- CMT United States
- Employees
- TARA N/A
- CMT N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- CMT Electronic Components
- Sector
- TARA Health Care
- CMT Consumer Discretionary
- Exchange
- TARA Nasdaq
- CMT Nasdaq
- Market Cap
- TARA 165.5M
- CMT 185.6M
- IPO Year
- TARA N/A
- CMT N/A
- Fundamental
- Price
- TARA $7.59
- CMT $18.59
- Analyst Decision
- TARA Strong Buy
- CMT
- Analyst Count
- TARA 7
- CMT 0
- Target Price
- TARA $20.33
- CMT N/A
- AVG Volume (30 Days)
- TARA 613.6K
- CMT 22.2K
- Earning Date
- TARA 11-10-2025
- CMT 11-04-2025
- Dividend Yield
- TARA N/A
- CMT N/A
- EPS Growth
- TARA N/A
- CMT N/A
- EPS
- TARA N/A
- CMT 0.93
- Revenue
- TARA N/A
- CMT $261,619,000.00
- Revenue This Year
- TARA N/A
- CMT N/A
- Revenue Next Year
- TARA N/A
- CMT $6.42
- P/E Ratio
- TARA N/A
- CMT $20.29
- Revenue Growth
- TARA N/A
- CMT N/A
- 52 Week Low
- TARA $2.28
- CMT $12.25
- 52 Week High
- TARA $10.48
- CMT $22.29
- Technical
- Relative Strength Index (RSI)
- TARA 77.80
- CMT 49.53
- Support Level
- TARA $5.00
- CMT $17.36
- Resistance Level
- TARA $6.85
- CMT $19.17
- Average True Range (ATR)
- TARA 0.55
- CMT 0.83
- MACD
- TARA 0.24
- CMT 0.02
- Stochastic Oscillator
- TARA 99.43
- CMT 44.22
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About CMT Core Molding Technologies Inc
Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam, and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.